UBC, a biopharmaceutical company providing integrated clinical, safety and commercialization services, has acquired Examoto, LLC, a risk evaluation and mitigation strategy (REMS) company. Examoto is dedicated to the design, development, deployment and streamlined operation of technologically driven REMS services in the pharmaceutical market. Transaction terms were not disclosed. “We are excited by the compelling opportunities this acquisition presents to expand the industry’s leading one-stop...